Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opiant Pharmaceuticals Inc (NQ: OPNT )

14.66 +0.61 (+4.34%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,093
Open 14.29
Bid (Size) 7.000 (1)
Ask (Size) 15.49 (4)
Prev. Close 14.05
Today's Range 14.24 - 14.88
52wk Range 7.340 - 37.71
Shares Outstanding 4,399,675
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Soaring Today
 
Via Benzinga

Performance

YTD
-56.36%
-56.36%
1 Month
-24.00%
-24.00%
3 Month
-45.80%
-45.80%
6 Month
-40.79%
-40.79%
1 Year
+14.89%
+14.89%

More News

Read More
Earnings Scheduled For November 11, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Via Benzinga
99 Biggest Movers From Yesterday
Via Benzinga
Earnings Scheduled For May 10, 2022
Via Benzinga
A Preview Of Opiant Pharmaceuticals's Earnings
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Via Benzinga
President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters
Via Benzinga
Looking Into Opiant Pharmaceuticals's Return On Capital Employed
Via Benzinga
Opiant Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Opiant Pharmaceuticals's Earnings Outlook
Via Benzinga
Opiant's Multi-Dose Nasal Nalmefene Shows Safety, Tolerability In Opioid Overdose
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Via Benzinga
Earnings Scheduled For March 15, 2022
Via Benzinga
Under BARDA Contract, Opiant Pharma Secures Additional Funding Of $2M For Opioid Overdose Program
Via Benzinga
The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
Via Benzinga
Opiant Pharma Starts Dosing In OPNT002 Mid-Stage Study For Alcohol Use Disorder
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
Via Benzinga
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Via Benzinga
Exposures COVID-19 Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.